Medicine–food homologous bioactives in metabolic dysregulation-associated osteoporosis: a review of preclinical evidence and potential liver–bone and gut–bone actions
Osteoporosis is increasingly linked to metabolic dysregulation. Medicine–food homologous (MFH) materials contain diverse natural bioactives with reported osteoprotective effects, but their overall evidence landscape remains insufficiently integrated. To synthesize preclinical evidence on MFH-derived bioactives that imp...